Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Ingenta contracts and ex-dividends

AIM movers: Revolution Beauty returns and Aferian reaches new low

CAB Payments sets offer price

AIM Movers: Microsaic Systems recovers and Physiomics falls to just above placing price

IOG increases gas rates and Microsaic Systems short of cash

A beneficiary of the new UK Biological Security Strategy

Aquis weekly movers: Coinsilium share price recovery

AIM weekly movers: Strip Tinning share buying

Non-Standard Finance shareholders set to get nothing

AIM movers: Pelatro contract success and weak advertising at Audioboom

AIM movers: Biome Technologies contract and poor flows for Falcon Oil & Gas

Esken falls despite significant break up value

AIM movers: i-nexus convertible funding and Live Company’s late accounts

Gear4Music has platform for recovery

Frasers buys stake in boohoo

AIM movers: Vertu Motors higher on Lookers bid and Capital Metals discount placing

Signs of recovery at musicMagpie

AIM movers: Litigation Capital award and Allergy Therapeutics returns from suspension

Momentum sustained at AIM asset manager

Aquis weekly movers: SulNOx Group US patent

AIM weekly movers: Sancus Lending recovery

AIM movers: Better outlook for CT Automotive and Marlowe considers disposal

Why companies left AIM in May 2023

JLEN Environmental increases NAV by 7%.

AIM movers: Eden Research flowers in Colombia and ex-dividends

Marks Electrical continues share gain

AIM movers: Aptamer Alzheimer’s test success and GCM Resources discount

AIM movers: Yourgene sells Taiwan subsidiary and Sound Energy obtains financing deal

New standard listing: Altona Rare Earths

AIM movers: Quadrise collaboration and Myanmar Investment NAV falls by two-thirds

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020